You are now viewing 31 - 40 of 170 results
March 27, 2008 | Journal Article
This article considers the effects of the deadlines imposed on the Food and Drug Administration by the Prescription Drug User Fee Act. The Act was intended to expedite the review process, but according to these findings may have compromised safety.
April 1, 2008 | Journal Article
Current FDA, FTC, and FCC guidelines governing product placements in entertainment are extremely vague. Although the pharmaceutical industry has not used this marketing tool heavily, the possibility for abuse of it by the industry remains real. Stricter guidelines should be developed.
August 19, 2008 | Journal Article
Seeding trials are clinical studies conducted by pharmaceutical companies designed to seem as if they answer a scientific question, but primarily fulfill marketing objectives they have not been described in detail.
September 1, 2008 | Commentary
An intensified focus on drug safety often leads to demands for more data collection prior to drug approval. Increased post-marketing surveillance can also play an important role, but the optimal approach must be chosen for each case as it arises.
January 1, 2007 | Journal Article
Effects of Losing Prescription Drug Coverage.
February 1, 2007 | Journal Article
Congress debated a bill on adding prescription drug coverage to Medicare for nearly a decade and passed an inadequate plan in 2003,
June 20, 2007 | Journal Article
Drug classes with the most frequent coverage were found to have at least one drug not covered by two-thirds of formularies.
September 10, 2007 | Journal Article
The present article considered cardiovascular patients' adherence to physicians' medication recommendations. Nonadherence was defined as following the suggested medicine regiment 75 percent or less of the time. Study participants were 1,015 outpatie ...
December 9, 2005 | Program Result Report
Richard A. Rawson, Ph.D., evaluated the reasons why naltrexone (a medication-based treatment for alcohol abuse and dependence and opiate addiction) is not widely used by physicians and practitioners.
April 1, 2004 | Program Result Report
California Health Decisions developed a statewide, pilot education initiative called Healthcare 101: Choosing and Using Prescription Medicines.